MASIMO CORPORATION (MASI)

symbol lookup

Follow MASI via My Validea and receive an email alert whenever any of our strategies changes its rating.

Get Started
Score: 93/100
Analysis based upon 11/17/2017 closing price.
Latest Close: $86.55 Market Cap ($ mil): $4,472 Sector: Healthcare Industry: Medical Equipment & Supplies Debt/Equity: 0.00
PE Ratio: 13.7 Price/Sales: 5.9 Price/Book: 6.2 Yield: N/A Return on Equity: 66.0%
52 Week High: $104.71 52 Week Low: $60.31 Relative Strength: 79 LT EPS Growth: 55.8% LT Sales Growth: 8.9%
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Report Card - Patient Investor

Guru Criteria: Warren Buffett  
EARNINGS PREDICTABILITY:PASS
DEBT SERVICE:PASS
RETURN ON EQUITY:PASS
RETURN ON TOTAL CAPITAL:PASS
FREE CASH FLOW:PASS
USE OF RETAINED EARNINGS:PASS
SHARE REPURCHASE:PASS
INITIAL RATE OF RETURN:PASS
EXPECTED RETURN:PASS

Detailed Analysis

Get a full analysis of MASI using this and 11 other strategies of investment legends.

Start Your Free Trial